New Clot-Removing device tested in japan for dangerous blood clots
NCT ID NCT06871683
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is tracking 100 patients in Japan who receive the ClotTriever device to treat severe deep vein thrombosis (DVT). The device is used to remove blood clots from deep veins. Researchers are checking how safe the device is and how well it clears the clot in everyday hospital use. The goal is to confirm the device works well after it was approved for sale in Japan.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ClotTriever Thrombectomy System (a device that removes blood clots from veins)
What this could lead to
If successful, this could confirm that the ClotTriever device is a safe and effective option for treating severe deep vein thrombosis in routine practice.
What could go wrong
This is an observational survey, not a controlled trial, so results may be less definitive. Risks include bleeding, new blood clots, or device-related complications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEEP VEIN THROMBOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Asahi General Hospital
Chiba, 289-2511, Japan
-
Asahikawa Medical Hospital
Asahikawa, 078-8510, Japan
-
Chiba University Hospital
Chuo, Chiba, 260-8677, Japan
-
Keio University
Tokyo, 160-8582, Japan
-
Kyoto Katsura Hospital
Kyoto, 615-8256, Japan
-
Mie University
Tsu, 514-0102, Japan
-
Mitsui Memorial Hospital
Tokyo, 101-8643, Japan
-
Nara City Hospital
Nara, 630-8305, Japan
-
National Cerebral and Cardiovascular Center
Suita, Osaka, 564-8565, Japan
-
Nozaki Tokushukai Hospital
Daitō, 574-0074, Japan
-
Osaka Police Hospital
Osaka, 543-0042, Japan
-
Ota Memorial Hospital
Ōta, Gunma, 373-8585, Japan
-
Shonan Kamakura
Kanagawa, 247-8533, Japan
-
St. Marianna University Hospital
Kawasaki, Kanagawa, 216-8511, Japan